"The US Food and Drug Administration (FDA) has approved a riboflavin ophthalmic solution (Photrexa, Avedro) that treats a corneal disease called progressive keratoconus with corneal collagen crosslinking, the manufacturer announced today."...
Ocular Or Periocular Infections
EYLEA is contraindicated in patients with ocular or periocular infections.
Active Intraocular Inflammation
EYLEA is contraindicated in patients with active intraocular inflammation.
EYLEA is contraindicated in patients with known hypersensitivity to aflibercept or any of the excipients in EYLEA. Hypersensitivity reactions may manifest as severe intraocular inflammation.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 6/7/2016
Additional Eylea Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.